| RS1057519667 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1057519668 |
LDLR
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, familial |
| RS1057519669 |
LDLR
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, familial |
| RS1057519670 |
LDLR
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, familial |
| RS1057519671 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1057519672 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1057519673 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1057519674 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1057519675 |
LDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS1057519676 |
LDLR
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypercholesterolemia, familial |
| RS1057519677 |
LDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS1057519679 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1057519682 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1057519683 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1057519685 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1057519686 |
LDLR
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, familial |
| RS1057519687 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1057519690 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1057519691 |
PCSK9
|
Health Risk |
Pathogenic |
Hypercholesterolemia, autosomal dominant |
| RS1057519697 |
ALK
|
Health Risk |
Likely pathogenic |
ALK-related disorder, Neuroblastoma |
| RS1057519698 |
ALK
|
Health Risk |
Pathogenic |
Neuroblastoma, Neuroblastoma |
| RS1057519708 |
KIT
|
Health Risk |
Pathogenic/Likely pathogenic |
Gastrointestinal stromal tumor, Germinomatous germ cell tumor |
| RS1057519710 |
KIT
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS1057519713 |
KIT
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Germ cell tumor of testis |
| RS1057519718 |
BRAF
|
Health Risk |
Likely pathogenic |
Gallbladder cancer, Gallbladder cancer |
| RS1057519724 |
PTEN
|
Health Risk |
Likely pathogenic |
PTEN hamartoma tumor syndrome, Neoplasm |
| RS1057519725 |
KRAS
|
Health Risk |
Pathogenic/Likely pathogenic |
OCULOECTODERMAL SYNDROME, SOMATIC |
| RS1057519729 |
MAP2K1
|
Health Risk |
Pathogenic |
Non-small cell lung carcinoma, Melorheostosis |
| RS1057519730 |
MAP2K1
|
Health Risk |
Pathogenic |
RASopathy, RASopathy |
| RS1057519732 |
MAP2K1
|
Health Risk |
Likely pathogenic |
Noonan syndrome, Cardiofaciocutaneous syndrome 3 |
| RS1057519733 |
MAP2K1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Cardiofaciocutaneous syndrome 3 |
| RS1057519736 |
IDH2
|
Health Risk |
Pathogenic |
Acute myocardial infarction, Vascular malformation |
| RS1057519739 |
SMAD4
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Hereditary cancer-predisposing syndrome |
| RS1057519742 |
GNA11
|
Health Risk |
Pathogenic |
See cases, Neoplasm |
| RS1057519747 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-Fraumeni syndrome, Adrenocortical carcinoma |
| RS1057519748 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Inborn genetic diseases |
| RS1057519749 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS1057519750 |
RUNX1
|
Health Risk |
Likely pathogenic |
Acute myeloid leukemia, Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 |
| RS1057519751 |
RUNX1
|
Health Risk |
Pathogenic |
Abnormal platelet function, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS1057519757 |
PIK3R1
|
Health Risk |
Pathogenic |
Vascular Malformations and Overgrowth, Neoplasm |
| RS1057519779 |
MTOR
|
Health Risk |
Pathogenic |
Isolated focal cortical dysplasia type II, Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes |
| RS1057519784 |
ALK
|
Health Risk |
Likely pathogenic |
Lung cancer, Lung cancer |
| RS1057519787 |
ERBB2
|
Health Risk |
Pathogenic |
Malignant tumor of urinary bladder, Malignant tumor of urinary bladder |
| RS1057519788 |
ROS1
|
Health Risk |
Pathogenic |
Lung adenocarcinoma, Lung adenocarcinoma |
| RS1057519801 |
PIK3R2
|
Health Risk |
Likely pathogenic |
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1, Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 |
| RS1057519805 |
MAP2K1
|
Health Risk |
Likely pathogenic |
Cardiofaciocutaneous syndrome 3, Cardiofaciocutaneous syndrome 3 |
| RS1057519806 |
MAP2K2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiofaciocutaneous syndrome 4, Cardio-facio-cutaneous syndrome |
| RS1057519816 |
ERBB2
|
Health Risk |
Pathogenic |
— |
| RS1057519825 |
BTK
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked agammaglobulinemia with growth hormone deficiency, Malignant lymphoma |
| RS1057519826 |
BTK
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1057519838 |
PIK3R1
|
Health Risk |
Pathogenic/Likely pathogenic |
Immunodeficiency 36 with lymphoproliferation, SHORT syndrome |
| RS1057519841 |
PIK3R1
|
Health Risk |
Pathogenic |
Vascular Malformations and Overgrowth, Vascular malformation |
| RS1057519852 |
CDKN2A
|
Health Risk |
Pathogenic |
Familial melanoma, Familial melanoma |
| RS1057519879 |
B2M
|
Health Risk |
Likely pathogenic |
Amyloidosis, hereditary systemic 6 |
| RS1057519881 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Melanoma-pancreatic cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1057519882 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS1057519884 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1057519893 |
ERBB3
|
Health Risk |
Pathogenic |
Malignant tumor of urinary bladder, Neoplasm |
| RS1057519896 |
FBXW7
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1057519906 |
IDH2
|
Health Risk |
Likely pathogenic |
Acute myocardial infarction, Neoplasm |
| RS1057519909 |
MAP2K1
|
Health Risk |
Pathogenic |
— |
| RS1057519910 |
MAP2K2
|
Health Risk |
Pathogenic |
RASopathy, RASopathy |
| RS1057519911 |
MAPK1
|
Health Risk |
Pathogenic/Likely pathogenic |
6 conditions, Noonan syndrome 13 |
| RS1057519914 |
MTOR
|
Health Risk |
Pathogenic |
Hemimegalencephaly, Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes |
| RS1057519915 |
MTOR
|
Health Risk |
Likely pathogenic |
Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome, Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome |
| RS1057519917 |
MTOR
|
Health Risk |
Likely pathogenic |
— |
| RS1057519922 |
NFE2L2
|
Health Risk |
Pathogenic |
Immunodeficiency, developmental delay |
| RS1057519925 |
PIK3CA
|
Health Risk |
Pathogenic |
Ovarian neoplasm, Megalencephaly-capillary malformation-polymicrogyria syndrome |
| RS1057519927 |
PIK3CA
|
Health Risk |
Likely pathogenic |
Lip and oral cavity carcinoma, Inborn genetic diseases |
| RS1057519929 |
PIK3CA
|
Health Risk |
Pathogenic |
Abnormal cardiovascular system morphology, CLOVES syndrome |
| RS1057519930 |
PIK3CA
|
Health Risk |
Conflicting classifications of pathogenicity |
Cowden syndrome, CLOVES syndrome |
| RS1057519933 |
PIK3CA
|
Health Risk |
Conflicting classifications of pathogenicity |
Cowden syndrome 5, PIK3CA related overgrowth syndrome |
| RS1057519936 |
PIK3CA
|
Health Risk |
Likely pathogenic |
Megalencephaly-capillary malformation-polymicrogyria syndrome, Megalencephaly-capillary malformation-polymicrogyria syndrome |
| RS1057519938 |
PIK3CA
|
Health Risk |
Pathogenic |
Noonan syndrome 8, Megalencephaly-capillary malformation-polymicrogyria syndrome |
| RS1057519941 |
PIK3CA
|
Health Risk |
Likely pathogenic |
Ovarian neoplasm, Neoplasm |
| RS1057519942 |
PIK3CA
|
Health Risk |
Pathogenic |
Cowden syndrome, Cowden syndrome 5 |
| RS1057519943 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Programmed death ligand-1 (PD-L1) blocking antibody response, Endometrioid adenocarcinoma |
| RS1057519945 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
POLE-related disorder, POLE-related disorder |
| RS1057519946 |
PPP2R1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Houge-Janssens syndrome 2, Colon adenocarcinoma |
| RS1057519947 |
PPP2R1A
|
Health Risk |
Likely pathogenic |
Houge-Janssens syndrome 2, Intellectual disability |
| RS1057519950 |
RHEB
|
Health Risk |
Pathogenic |
— |
| RS1057519961 |
SF3B1
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS1057519963 |
SOS1
|
Health Risk |
Likely pathogenic |
Noonan syndrome 4, Noonan syndrome 4 |
| RS1057519975 |
TP53
|
Health Risk |
Pathogenic |
Li-Fraumeni syndrome, Li-Fraumeni syndrome 1 |
| RS1057519976 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome |
| RS1057519977 |
TP53
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome |
| RS1057519978 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome |
| RS1057519980 |
TP53
|
Health Risk |
Pathogenic |
Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome |
| RS1057519981 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome |
| RS1057519982 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome |
| RS1057519983 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome |
| RS1057519984 |
TP53
|
Health Risk |
Pathogenic/Likely pathogenic |
Li-Fraumeni syndrome, Ovarian neoplasm |
| RS1057519985 |
TP53
|
Health Risk |
Likely pathogenic |
Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome |
| RS1057519986 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-Fraumeni syndrome, Li-Fraumeni syndrome 1 |
| RS1057519987 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome |
| RS1057519988 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Ovarian neoplasm, Li-Fraumeni syndrome |
| RS1057519989 |
TP53
|
Health Risk |
Pathogenic |
Li-Fraumeni syndrome, Familial cancer of breast |
| RS1057519990 |
TP53
|
Health Risk |
Pathogenic |
Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome |
| RS1057519991 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-Fraumeni syndrome, Ovarian neoplasm |
| RS1057519992 |
TP53
|
Health Risk |
Likely pathogenic |
Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome |